Study Proves Avandia Does Not Cause Heart Attacks

Results of a new study have found no risk of heart health issues in patients given the drug avandia to help treat their diabetes.

Avandia is manufactured by GlaxoSmithKline and is prescribed to people suffering with diabetes. Read more

Merck’s Rolofylline Fails To Meet Study Goals

It is being reported that Merck will not be applying to the FDA for approval of their heart failure drug because it did not meet study goals.

Heart failure occurs when the heart becomes weak to the point where it is unable to sufficiently pump blood throughout the entire body. Read more

Johnson And Johnson Developing Drug For Resistant Tuberculosis

There is a new experimental drug being developed by Johnson and Johnson that has shown promise at treating drug resistant tuberculosis.

The drug is called TMC207, and is in early stages of development but so far, the results have been very positive. Read more

FDA Wants More Clinical Data On Cinryze Drug

The Food and Drug Administration (FDA) have sent a complete response letter to ViroPharma concerning their experimental drug, Cinryze.

The drug was developed to treat a rare genetic medical condition, but according to the FDA the company have not proven that it can be used as an effective treatment. Read more

(Update) Pfizer Develops Drug To Fight Cancer In Dogs

The Food and Drug Administration (FDA) have approved Palladia, the world’s first drug specifically developed to treat cancer in dogs.

The drug is manufactured by Pfizer Inc, and according to the company will be ready for distribution sometime next year. Read more

Drug Makers Join Forces To Fight Bad Cholesterol

It is being reported that AstraZeneca in combination with Abbott have filed an approval application to the Food and Drug Administration for their cholesterol drug.

Their drug goes by the name of Certriad, and is a combination pill containing both Crestor and TriLipix for the lowering of bad levels of cholesterol. Read more

Consumer Group: FDA Should Stop Review Of Blood Thinner

A consumer group is requesting that the Food and Drug Administration (FDA) stop the review of an Eli Blood thinning drug called prasugrel.

According to Public Citizen, the recommended dosage instructions for the drug are far too high, a fact that puts patients who receive it at increased risk of internal bleeding. Read more

(Update) Treating Autistic Children With Antidepressants May Worsen Condition

Autistic children treated with the antidepressant drug Celexa were no more likely to have reduced symptoms of their condition say researchers of a new study.

Celexa is commonly prescribed for children with autism as doctors feel it works to reduce bouts of abnormal behavior. Read more

Cervical Cancer Vaccine Reduces Risk Of HPVs In Older Women

Results of a new study show that the cervical cancer vaccine called gardasil can also protect older women from contracting the disease.

Originally it was thought that the vaccine was only good for females 9 to 26 years of age but this appears not to be the case. Read more

Experimental Antidepressant Drug Meets Clinical Trial Goals

An experimental drug for treating depression made by Clinical Data Inc has met preliminary goals in a study.

The drug is called vilazodone, and is for treating people who experience a type of depression called major depressive disorders. Read more

« Previous Page — Next Page »